Article
Endocrinology & Metabolism
Xinli Wang, Yan Xue
Summary: This study compared ER(-)/PR(+) breast cancer with other subtypes and found that it is more similar to ER(-)/PR(-) breast cancer, with characteristics such as early age of onset, high proportion of infiltrating non-special types, high histological grade, and high HER-2 positivity rate. The study suggests that HER-2 positivity may improve the prognosis of ER(-)/PR(+) breast cancer.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Oncology
Hyuna Sung, Rachel A. Freedman, Rebecca L. Siegel, Noorie Hyun, Carol E. DeSantis, Kathryn J. Ruddy, Ahmedin Jemal
Summary: Compared with the general population, breast cancer survivors with HR-positive cancers have a 20% higher risk of subsequent primary cancers, while those with HR-negative cancers have a 44% higher risk. The increased risk after HR-negative cancer is mainly driven by specific types of cancers. Moreover, the risks of subsequent primary cancers after breast cancer vary significantly depending on subtype and age at diagnosis.
Article
Health Care Sciences & Services
Mengwei Zhang, Min Yan, Huimin Lv, Limin Niu, Huiai Zeng
Summary: The study found that ER+/PR+ advanced breast cancer patients have better prognosis than ER+/PR- patients undergoing first-line endocrine therapy. Additionally, PR status is an independent predictor of treatment response in hormone receptor-positive HER2 negative patients.
ANNALS OF PALLIATIVE MEDICINE
(2021)
Article
Oncology
Richard A. Anderson, Matteo Lambertini, Peter S. Hall, W. Hamish Wallace, David S. Morrison, Tom W. Kelsey
Summary: This study found that having a live birth after breast cancer does not have a negative impact on overall survival, especially for younger women who have not been pregnant before. The interaction between subsequent childbirth and survival increases with decreasing age. Women with different ER statuses and those who have received chemotherapy have similar survival rates after subsequent childbirth.
EUROPEAN JOURNAL OF CANCER
(2022)
Article
Multidisciplinary Sciences
Iwona Sidorkiewicz, Maciej Jozwik, Angelika Buczynska, Anna Erol, Marcin Jozwik, Marcin Moniuszko, Katarzyna Jarzabek, Magdalena Niemira, Adam Kretowski
Summary: Aberrant metabolism has been identified as a main driver of cancer. In this study, transcriptomic profiles of metabolism-related pathways in endometrial cancer (EC) were established using NanoString nCounter Technology. 11 deregulated genes associated with 'central carbon metabolism in cancer' were identified, and drug repurposing validated several drug candidates. These findings have significant implications for personalized therapeutic strategies in EC.
SCIENTIFIC REPORTS
(2023)
Article
Clinical Neurology
Chen Jiaxin, Zhou Jinmei, Zhang Huiqiang, Wu Xuexue, Wang Xiaobo, Zhang Shaohua, Tai Yanhong, Jiang Zefei, Wang Tao
Summary: This study analyzed the expression levels of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2), and Ki-67 proliferation index in Chinese patients with breast cancer brain metastasis (BCBM), and found a correlation between their changes and patients' survival.
FRONTIERS IN NEUROLOGY
(2022)
Article
Oncology
Emine C. Koc, Fatih C. Koc, Funda Kartal, Maria Tirona, Hasan Koc
Summary: Remodeling of mitochondrial energy metabolism is crucial for the survival of tumor cells under limited nutrient and hypoxic conditions, and aberrant expressions of mitochondrial translation components have been associated with breast cancer. Understanding the role of MRPs in energy metabolism remodeling is essential for the diagnosis and prognosis of breast cancer.
FRONTIERS IN ONCOLOGY
(2022)
Article
Medicine, Research & Experimental
Peiling Xie, Rui An, Shibo Yu, Jianjun He, Huimin Zhang
Summary: This study identified and validated five heterogeneous immune subtypes among ER+/PR-/HER2- breast cancer, each with distinct cellular and molecular characteristics, potential immune escape mechanisms, genomic drivers, and clinical outcomes. An immune-cold subtype had a poorer prognosis, while an immune-hot subtype showed the highest infiltration of immune cells and a better prognosis. The analysis revealed a complex immune landscape with discrete clusters and a continuous spectrum.
JOURNAL OF TRANSLATIONAL MEDICINE
(2021)
Review
Oncology
Paulina Miziak, Marzena Baran, Ewa Blaszczak, Alicja Przybyszewska-Podstawka, Joanna Kalafut, Jolanta Smok-Kalwat, Magdalena Dmoszynska-Graniczka, Michal Kielbus, Andrzej Stepulak
Summary: ER signaling is a critical regulator in breast cancer and other hormone-sensitive cancers. This article reviews the mechanism of ER-dependent downstream signaling in breast cancer and discusses the clinical implications of ER signaling, including potential endocrine therapies. The challenges associated with therapy resistance caused by acquired ER mutations and potential strategies to overcome them are also discussed.
Article
Biochemistry & Molecular Biology
Marko Hojnik, Masa Sinreih, Maja Anko, Neli Hevir-Kene, Tamara Knific, Bostjan Pirs, Snjezana Frkovic Grazio, Tea Lanisnik Rizner
Summary: Estrogens play an important role in endometrial cancer through ERα, ERβ, and GPER. This study found decreased levels of ERα and lower protein levels of ERβ and GPER in EC tissue. Significant correlations were observed between ESR1 and ESR2, as well as GPER variant 3,4 and ESR1 and ESR2 at the mRNA level. Further studies are needed to examine the potential of ERβ and GPER as prognostic markers, provided that specific and validated antibodies are available.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Oncology
Yilun Li, Li Ma
Summary: This study found a negative association between telomere length and the prognosis of breast cancer, particularly with ER- breast cancer. However, no significant correlation was found between telomere length and the prognosis of ER+ breast cancer.
FRONTIERS IN ONCOLOGY
(2022)
Article
Multidisciplinary Sciences
Ayey Madut, Veronika Fuchsova, Hong Man, Shabeel Askar, Ritu Trivedi, Elisabeth Elder, Christine L. Clarke, Gerard Wain, Alison Brand, Anna DeFazio, Terence Amis, Kristina Kairaitis
Summary: This study found a high prevalence of obstructive sleep apnea (OSA) in postmenopausal women with breast cancer (BC) and endometrial cancer (EC), but no significant associations were detected between OSA metrics and specific tumor characteristics.
Review
Oncology
Charles Dai, Leif W. Ellisen
Summary: Aberrant estrogen receptor (ER) signaling plays a key role in the development of many breast cancers. The androgen receptor (AR), similar to ER, is frequently expressed in breast cancer and has been considered as a potential therapeutic target. However, the understanding of androgen signaling in breast cancer is incomplete and there are conflicting findings regarding the role of AR. This article summarizes the current understanding of AR biology and recent investigations into AR-directed therapies in breast cancer.
Article
Medicine, General & Internal
M. R. Mirza, D. M. Chase, B. M. Slomovitz, R. dePont Christensen, Z. Novak, D. Black, L. Gilbert, S. Sharma, G. Valabrega, L. M. Landrum, L. C. Hanker, A. Stuckey, I. Boere, M. A. Gold, A. Auranen, B. Pothuri, D. Cibula, C. McCourt, F. Raspagliesi, M. S. Shahin, S. E. Gill, B. J. Monk, J. Buscema, T. J. Herzog, L. J. Copeland, M. Tian, Z. He, S. Stevens, E. Zografos, R. L. Coleman, M. A. Powell
Summary: Dostarlimab plus carboplatin-paclitaxel significantly improved progression-free survival in patients with endometrial cancer, particularly in the mismatch repair-deficient microsatellite instability-high population.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Article
Oncology
Serena C. Houghton, Heather Eliassen, Rulla M. Tamimi, Walter C. Willett, Bernard A. Rosner, Susan E. Hankinson
Summary: The study found a positive association between central adiposity (waist and hip circumference) and breast cancer risk, especially in premenopausal women. In contrast, waist circumference, hip circumference, and waist-to-hip ratio were not significantly associated with breast cancer risk in postmenopausal women, regardless of BMI adjustment. Therefore, maintaining a healthy waist circumference may help reduce both pre- and postmenopausal breast cancer risk.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2021)
Article
Biochemistry & Molecular Biology
Yun Ling, Gehao Liang, Qun Lin, Xiaolin Fang, Qing Luo, Yinghuan Cen, Maryam Mehrpour, Ahmed Hamai, Zihao Liu, Yu Shi, Juanmei Li, Wanyi Lin, Shijie Jia, Wenqian Yang, Qiang Liu, Erwei Song, Jun Li, Chang Gong
Summary: The study identified a circRNA circCDYL2 that is overexpressed in HER2(+) breast cancer patients resistant to trastuzumab, playing a critical role in maintaining HER2 signaling and contributing to trastuzumab resistance. High levels of circCDYL2 were associated with rapid recurrence and shorter survival in HER2(+) breast cancer patients, suggesting circCDYL2 as a potential biomarker for trastuzumab resistance.
Editorial Material
Biology
Jing Zhou, Wang Yang, Qiang Liu
SCIENCE CHINA-LIFE SCIENCES
(2022)
Article
Oncology
Yi-Xin Zhang, Zhuo-Zhi Liang, Yun-Qian Li, Ying Lin, Qiang Liu, Xiao-Ming Xie, Lu-Ying Tang, Ze-Fang Ren
Summary: The association between weight change after breast cancer diagnosis and prognosis is inconsistent. Menopausal status and endocrine therapy have modifying effects on this association. Weight loss increases the risk of breast cancer progression, especially in post-menopausal women, while weight gain may reduce the risk of disease progression among patients with endocrine therapy.
BREAST CANCER RESEARCH AND TREATMENT
(2022)
Article
Biology
Zijie Cai, Jingru Wang, Yudong Li, Qianfeng Shi, Liang Jin, Shunying Li, Mengdi Zhu, Qi Wang, Lok Lam Wong, Wang Yang, Hongna Lai, Chang Gong, Yandan Yao, Yujie Liu, Jun Zhang, Herui Yao, Qiang Liu
Summary: CDK4/6 inhibitors are standard treatment for advanced HR+/HER2- breast cancer, but resistance is inevitable. This study found that overexpression of Cyclin D1 and CDK4 proteins leads to resistance, and targeting the PI3K/mTOR pathway can restore sensitivity.
SCIENCE CHINA-LIFE SCIENCES
(2023)
Article
Multidisciplinary Sciences
Xueman Chen, Rong Luo, Yunmei Zhang, Shuying Ye, Xin Zeng, Jiang Liu, Di Huang, Yujie Liu, Qiang Liu, Man-Li Luo, Erwei Song
Summary: This study identifies a long noncoding RNA DIO3OS as a driver of AI-resistance in breast cancer through the enhancement of aerobic glycolysis, highlighting its potential as a therapeutic target to reverse AI resistance in estrogen receptor positive breast cancer.
NATURE COMMUNICATIONS
(2022)
Article
Oncology
Liu Yang, Wei Du, Taobo Hu, Miao Liu, Li Cai, Qiang Liu, Zhigang Yu, Guangyu Liu, Shu Wang
Summary: This multicenter real-world study showed that intensive postoperative bone scan screening improved survival for breast cancer patients with bone metastasis, especially for those at clinical high-risk.
Article
Engineering, Biomedical
Yi You, Yu Tian, Zhaogang Yang, Junfeng Shi, Kwang Joo Kwak, Yuhao Tong, Andreanne Poppy Estania, Jianhong Cao, Wei-Hsiang Hsu, Yutong Liu, Chi-Ling Chiang, Benjamin R. Schrank, Kristin Huntoon, DaeYong Lee, Ziwei Li, Yarong Zhao, Huan Zhang, Thomas D. Gallup, JongHoon Ha, Shiyan Dong, Xuefeng Li, Yifan Wang, Wen-Jing Lu, Eman Bahrani, Ly James Lee, Lesheng Teng, Wen Jiang, Feng Lan, Betty Y. S. Kim, Andrew S. Lee
Summary: The study found that extracellular vesicles (EVs) produced through cellular nanoporation can safely and effectively translate genetic material into functional proteins. In mice with photoaged skin, EVs carrying mRNA encoding for collagen induced collagen-protein grafts and reduced wrinkle formation. Intradermal delivery of mRNA-loaded EVs through a microneedle array resulted in prolonged and more uniform synthesis and replacement of collagen in the dermis. Intradermal delivery of EV-based COL1A1 mRNA may be an effective protein-replacement therapy for treating photoaged skin.
NATURE BIOMEDICAL ENGINEERING
(2023)
Article
Medicine, Research & Experimental
Fangming Cao, Keda Yang, Shui Qiu, Jie Li, Wen Jiang, Lin Tao, Yue Zhu
Summary: Oxidative stress is a major cause of osteoblast apoptosis in post-menopausal osteoporosis. Previous studies have shown that metformin can reverse the loss of bone mass in this condition. This study aimed to further investigate the effects and mechanisms of metformin under conditions of oxidative stress in post-menopausal osteoporosis.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
(2023)
Review
Oncology
Xiao-ting Jiang, Qiang Liu
Summary: Messenger RNA (mRNA) vaccination is highly successful against COVID-19 and has sparked tremendous interest. It is also viewed as a promising treatment strategy for cancer immunotherapy. However, breast cancer patients have limited access to immunotherapy benefits. This review discusses the potential of mRNA vaccination to convert cold breast cancer into hot and improve efficacy by combining appropriate vaccination platforms or other immunotherapies.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Multidisciplinary Sciences
Zijie Cai, Qianfeng Shi, Yudong Li, Liang Jin, Shunying Li, Lok Lam Wong, Jingru Wang, Xiaoting Jiang, Mengdi Zhu, Jinna Lin, Qi Wang, Wang Yang, Yujie Liu, Jun Zhang, Chang Gong, Herui Yao, Yandan Yao, Qiang Liu
Summary: This study reveals that a long non-coding RNA (EILA) that interacts with cyclin E1 is up-regulated in CDK4/6 inhibitor-resistant breast cancer cells and contributes to resistance by stabilizing cyclin E1 protein. EILA overexpression is associated with accelerated cell cycle progression and poor prognosis in breast cancer. Silencing EILA reduces cyclin E1 protein and restores sensitivity to CDK4/6 inhibitors both in vitro and in vivo.
Article
Biology
Jing Zhou, Mengdi Zhu, Qi Wang, Yiyuan Deng, Nianqiu Liu, Yujie Liu, Qiang Liu
Summary: Endocrine resistance is a major challenge in breast cancer therapy. Through screening five datasets, we identified 7 commonly dysregulated genes in endocrine-resistant breast cancer cells. Our study suggests that downregulation of SERPINA3, a direct target gene of estrogen receptor alpha, contributes to aromatase inhibitor resistance. ANKRD11 acts as a downstream effector of SERPINA3 in mediating endocrine resistance by interacting with HDAC3 and upregulating its activity.
COMMUNICATIONS BIOLOGY
(2023)
Review
Oncology
Kristin Huntoon, DaeYong Lee, Shiyan Dong, Abin Antony, Betty Y. S. Kim, Wen Jiang
Summary: Many patients with advanced or hard-to-treat cancer have seen improved outcomes with immunotherapy that targets adaptive immune checkpoints. However, innate immune checkpoints also play a crucial role in immune evasion by cancer cells and may be potential targets for cancer immunotherapy. This review discusses the disruption of phagocytic clearance by cancer cells and the potential impact of blocking phagocytosis checkpoints on activating anti-tumor immune responses. The authors propose a more effective combination immunotherapy strategy by targeting tumor-intrinsic processes that inhibit innate immune surveillance, such as phagocytosis, and incorporating both innate and adaptive immune responses.
Article
Medicine, Research & Experimental
Kristin Huntoon, Wen Jiang, Betty Y. S. Kim
Summary: The CD47/SIRP alpha axis plays a crucial role in cancer immune evasion, and targeting it can sensitize previously resistant colorectal cancer cells to immunotherapies. The study by Li et al. reveals that neddylation of SHP2 inhibits its activity and cotargeting SHP2 and immune checkpoints may be effective in immunotherapy-resistant tumors.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Jiafan Ma, Kai Chen, Shunrong Li, Liling Zhu, Yunfang Yu, Jingwu Li, Jie Ma, Jie Ouyang, Zhuo Wu, Yujie Tan, Zifan He, Haiqing Liu, Zhilong Pan, Haojiang Li, Qiang Liu, Erwei Song
Summary: An MRI-based radiomic model was developed to predict the risk of margin positivity in breast-conserving surgery. The model can stratify patients into different risk subgroups and is associated with tumor immune-microenvironment alterations.
EUROPEAN RADIOLOGY
(2023)